These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1881584)

  • 1. Successful use of recombinant human erythropoietin in pregnancy.
    McGregor E; Stewart G; Junor BJ; Rodger RS
    Nephrol Dial Transplant; 1991; 6(4):292-3. PubMed ID: 1881584
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythropoietin in pregnancies complicated by severe anemia of renal failure.
    Yankowitz J; Piraino B; Laifer SA; Frassetto L; Gavin L; Kitzmiller JL; Crombleholme W
    Obstet Gynecol; 1992 Sep; 80(3 Pt 2):485-8. PubMed ID: 1495715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful pregnancy in a patient with chronic renal failure undergoing haemodialysis].
    Furaz Czerpak KR; Puente García A; Corchete Prats E; Moreno MA; Martín Hernandez R
    Nefrologia; 2011; 31(2):219-21. PubMed ID: 21461018
    [No Abstract]   [Full Text] [Related]  

  • 4. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
    Eschbach JW; Haley NR; Adamson JW
    Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841
    [No Abstract]   [Full Text] [Related]  

  • 5. [Erythropoietin: from established therapeutic procedures in renal anemia to future areas of use].
    Marsen TA; Pollok M; Baldamus CA
    Med Klin (Munich); 1992 Apr; 87(4):207-14. PubMed ID: 1579099
    [No Abstract]   [Full Text] [Related]  

  • 6. Anemia treatment with erythropoietin in pregnant renal recipients.
    Cyganek A; Pietrzak B; Kociszewska-Najman B; Sanko-Resmer J; Paczek L; Wielgos M
    Transplant Proc; 2011 Oct; 43(8):2970-2. PubMed ID: 21996203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anemia treatment with darbepoetin alpha in pregnant female with chronic renal failure: report of two cases.
    Sobiło-Jarek L; Popowska-Drojecka J; Muszytowski M; Wanic-Kossowska M; Kobelski M; Czekalski S
    Adv Med Sci; 2006; 51():309-11. PubMed ID: 17357331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of recombinant erythropoietin therapy for renal transplantation.
    Ward HJ
    Am J Nephrol; 1990; 10 Suppl 2():44-7; discussion 48-52. PubMed ID: 2260618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of renal transplantation in patients treated with erythropoietin.
    Linde T; Wahlberg J; Wikström B; Danielson BG
    Clin Nephrol; 1992 May; 37(5):260-3. PubMed ID: 1606776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.
    Ramírez B; Flores A; Pérez F; Córdoba C; García L; Vázquez G
    Transplant Proc; 1991 Apr; 23(2):1833-4. PubMed ID: 2053170
    [No Abstract]   [Full Text] [Related]  

  • 11. Pregnancy in women with end-stage renal disease: treatment of anemia and premature labor.
    Hou S; Orlowski J; Pahl M; Ambrose S; Hussey M; Wong D
    Am J Kidney Dis; 1993 Jan; 21(1):16-22. PubMed ID: 8418619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications and contraindications for recombinant human erythropoietin treatment. Results in hemodialysis patients.
    Samtleben W; Baldamus CA; Bommer J; Grützmacher P; Nonnast-Daniel B; Scigalla P; Gurland HJ
    Contrib Nephrol; 1989; 76():193-200; discussion 212-8. PubMed ID: 2684521
    [No Abstract]   [Full Text] [Related]  

  • 13. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
    von Appen K; Klinkmann H
    Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to recombinant human erythropoietin (r-Hu EPO) and L-carnitine combination in patients with anemia of end-stage renal disease.
    Boran M; Dalva I; Gönenç F; Cetin S
    Nephron; 1996; 73(2):314-5. PubMed ID: 8773364
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance to rHuEpo and kidney graft rejection.
    Page B; Zingraff J
    Nephrol Dial Transplant; 1994; 9(11):1696. PubMed ID: 7870369
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and efficiency of recombinant human erythropoietin treatment in anemic pregnant women with a kidney transplant.
    Szurkowski M; Wiecek A; Kokot F; Daniel K
    Nephron; 1994; 67(2):242-3. PubMed ID: 8072619
    [No Abstract]   [Full Text] [Related]  

  • 17. The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis.
    Reddy SS; Holley JL
    Kidney Int; 2009 Jun; 75(11):1133-1134. PubMed ID: 19444267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of withdrawing erythropoietin.
    Taylor JE; Henderson IS; Mactier RA; Stewart WK
    BMJ; 1991 Feb; 302(6771):272-3. PubMed ID: 1998794
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of renal anemia with recombinant human erythropoietin.
    Schaefer RM; Hörl WH; Massry SG
    Am J Nephrol; 1989; 9(5):353-62. PubMed ID: 2679093
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.
    Binkley LS
    Transplant Proc; 1991 Apr; 23(2):1831-2. PubMed ID: 2053169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.